Courtesy of Beckman Coulter
 Beckman Coulter's ProteomeLab PF 2D Protein Fractionation System

Fullerton, Calif.-based Beckman Coulter recently announced a new program to tackle the development of tools for proteomics research from a systems biology standpoint. Called ProteomeLab™, the initiative integrates existing technology with new instrumentation and software to "simplify, automate, and standardize the multiple processes involved in protein research," says Jeff Chapman, strategic marketing manager for Beckman Coulter.

The ProteomeLab line breaks proteomics-based research into a series of steps--identification, isolation, fractionation, characterization, evaluation, and diagnosis--and aims to develop products that will function together seamlessly to take researchers from the early stages of disease marker identification through the development of diagnostic tests. "Our approach here is significantly different than other companies," explains Chapman, "in that rather than just looking at one area, we're looking at how to integrate, standardize, and automate these steps, and have them communicate with each other...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?